ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02974153
Brief Title: Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine (PROMISE 2)

First Submitted : November 23, 2016
First Submitted that Met QC Criteria : November 23, 2016
First Posted : November 28, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 14, 2018
Last Update Posted : August 16, 2018